Umut Kefeli

1.1k total citations
40 papers, 583 citations indexed

About

Umut Kefeli is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Umut Kefeli has authored 40 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 10 papers in Surgery. Recurrent topics in Umut Kefeli's work include Gastric Cancer Management and Outcomes (8 papers), Gastrointestinal Tumor Research and Treatment (5 papers) and Breast Cancer Treatment Studies (5 papers). Umut Kefeli is often cited by papers focused on Gastric Cancer Management and Outcomes (8 papers), Gastrointestinal Tumor Research and Treatment (5 papers) and Breast Cancer Treatment Studies (5 papers). Umut Kefeli collaborates with scholars based in Türkiye, United Kingdom and Cambodia. Umut Kefeli's co-authors include Ahmet Bılıcı, Mahmut Gümüş, Bala Başak Öven Ustaalıoğlu, Mesut Şeker, Taflan Salepçi, Emre Yıldırım, Berkant Sönmez, Mustafa Öncel, Mehmet Karaduman and Hülya Ilıksu Gözü and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Medicine.

In The Last Decade

Umut Kefeli

36 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Umut Kefeli Türkiye 12 260 184 173 95 76 40 583
Toshiyuki Fukuhara Japan 12 187 0.7× 210 1.1× 91 0.5× 54 0.6× 29 0.4× 27 582
Kazım Uygun Türkiye 15 215 0.8× 155 0.8× 312 1.8× 112 1.2× 20 0.3× 56 683
Ryoji Hyakudomi Japan 17 326 1.3× 336 1.8× 479 2.8× 48 0.5× 34 0.4× 49 775
Özlem Erçelep Türkiye 12 145 0.6× 72 0.4× 175 1.0× 64 0.7× 32 0.4× 55 366
José F. Carrillo Mexico 16 215 0.8× 453 2.5× 451 2.6× 100 1.1× 31 0.4× 40 879
Georg Wiltberger Germany 17 249 1.0× 357 1.9× 320 1.8× 104 1.1× 19 0.3× 59 762
Kentaro Hara Japan 14 276 1.1× 268 1.5× 229 1.3× 38 0.4× 35 0.5× 89 558
O. Horstmann Germany 13 412 1.6× 585 3.2× 388 2.2× 88 0.9× 92 1.2× 37 874
Agustín Seoane Spain 13 204 0.8× 189 1.0× 257 1.5× 45 0.5× 86 1.1× 40 524
Hang Yu China 15 312 1.2× 208 1.1× 197 1.1× 112 1.2× 48 0.6× 60 673

Countries citing papers authored by Umut Kefeli

Since Specialization
Citations

This map shows the geographic impact of Umut Kefeli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Umut Kefeli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Umut Kefeli more than expected).

Fields of papers citing papers by Umut Kefeli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Umut Kefeli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Umut Kefeli. The network helps show where Umut Kefeli may publish in the future.

Co-authorship network of co-authors of Umut Kefeli

This figure shows the co-authorship network connecting the top 25 collaborators of Umut Kefeli. A scholar is included among the top collaborators of Umut Kefeli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Umut Kefeli. Umut Kefeli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kefeli, Umut, et al.. (2025). Real-World Validation of the KELIM Score for Predicting Chemosensitivity and Survival in Advanced Ovarian Cancer. Turkish Journal of Clinics and Laboratory. 16(4). 564–569.
3.
4.
Kefeli, Umut, et al.. (2021). Perceptions and acceptance of telemedicine among medical oncologists before and during the COVID-19 pandemic in Turkey. Supportive Care in Cancer. 29(12). 7497–7503. 7 indexed citations
5.
Ustaalıoğlu, Bala Başak Öven, et al.. (2018). Clinical importance of discordance of hormone receptors and Her2/neu status after neoadjuvant chemotherapy in breast cancer.. PubMed. 19(4). 879–86. 5 indexed citations
6.
Ustaalıoğlu, Bala Başak Öven, Ahmet Bılıcı, Mesut Şeker, et al.. (2018). Prognostic Factors for Operated Gallbladder Cancer. Journal of Gastrointestinal Cancer. 50(3). 451–457. 10 indexed citations
7.
Ustaalıoğlu, Bala Başak Öven, et al.. (2017). The prognostic factors for operated gallbladder cancer. Annals of Oncology. 28. iii59–iii59. 3 indexed citations
8.
Kefeli, Umut, et al.. (2016). The value of plasma netrin-1 in non-small cell lung cancer patients as diagnostic and prognostic biomarker. Tumor Biology. 37(9). 11903–11907. 13 indexed citations
9.
Şendur, Mehmet Alı Nahıt, Umut Kefeli, Bala Başak Öven Ustaalıoğlu, et al.. (2016). Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma. Clinical Colorectal Cancer. 16(1). 78–83. 17 indexed citations
10.
Kefeli, Umut, Murat Akyol, Ramazan Yıldız, et al.. (2013). Efficacy of sunitinib in Turkish patients with gastrointestinal stromal tumors; retrospective multicenter experience.. PubMed. 60(124). 647–52. 4 indexed citations
11.
Kefeli, Umut, Mustafa Beneklı, Alper Sevinç, et al.. (2013). Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience. Oncology Letters. 6(2). 605–611. 9 indexed citations
12.
Korkmaz, Taner, S. Seber, Umut Kefeli, et al.. (2012). Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis. Clinical & Translational Oncology. 15(7). 535–540. 16 indexed citations
13.
Eser, Mehmet, Metin Kement, Umut Kefeli, et al.. (2012). Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer. World Journal of Surgical Oncology. 10(1). 180–180. 6 indexed citations
14.
Kefeli, Umut, Nurgül Yaşar, Özlem Erçelep, et al.. (2012). Netrin-1 concentrations in patients with advanced gastric cancer and its relation with treatment. Biomarkers. 17(7). 663–667. 17 indexed citations
15.
16.
Ustaalıoğlu, Bala Başak Öven, et al.. (2011). F-18 FDG PET/CT Imaging and Bronchoscopic Image of Tracheal Recurrence in Patient With Non–Small-Cell Lung Cancer. Clinical Nuclear Medicine. 36(5). 367–369. 1 indexed citations
17.
Ustaalıoğlu, Bala Başak Öven, Ahmet Bılıcı, Umut Kefeli, et al.. (2010). Does the Metastatic Lymph Node Ratio Influence the Disease-Free Survival of Patients with Breast Cancer: Single-Center Experiences. Oncology. 79(1-2). 105–111. 8 indexed citations
18.
Kefeli, Umut, Serap Kaya, Bala Başak Öven Ustaalıoğlu, et al.. (2010). Prognostic factors in elderly patients with non-small cell lung cancer: a two-center experience. Medical Oncology. 28(3). 661–666. 11 indexed citations
19.
Bılıcı, Ahmet, Bala Başak Öven Ustaalıoğlu, Mahmut Gümüş, et al.. (2010). Is Metastatic Lymph Node Ratio Superior to the Number of Metastatic Lymph Nodes to Assess Outcome and Survival of Gastric Cancer?. Oncology Research and Treatment. 33(3). 101–105. 15 indexed citations
20.
Kefeli, Umut, et al.. (2009). Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer. European Journal of Cancer Care. 18(2). 191–194. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026